• Home
  • Study Details
Coming Soon

Administration of T Cells Expressing CAR in Subjects with Head and Neck Squamous Cell Carcinoma

You have been asked to take part in this study because you have a type of cancer called Squamous Cell Carcinoma of the Head and Neck. This type of cancer usually starts in the squamous cells that line the moist surfaces inside the nose, mouth and throat. You have already received treatment for this cancer, however, the cancer came back or did not get better. This gene therapy study will use your own immune cells as treatment for your cancer. This treatment is experimental. It has not been approved by the Food and Drug Administration for treatment of your type of cancer. This study is done to investigate the safety, possible harms and side effects of administering modified immune cells in treating squamous cell carcinoma of the head and neck.

Age & Gender

  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive

Contact the Team

Location

Thank you for your interest, but this study will start enrolling soon.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Jared Weiss
LCCC - Clinical Trials

Study Type

Clinical or Medical
Interventional

Study Topics

Cancer (Head and Neck)

IRB Number

21-1294

Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research